Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • Blog
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • Blog
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Serum for Cell Culture and IgG
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Serum for Cell Culture and IgG

[1011-PC00B1] MSC-GRO VitroPlus III Low Serum Complete Medium - 500 mL
MSC-GRO VitroPlus III Low Serum Complete Medium - 500 mL
425.00 € 425.0 EUR
[0852-INV-1031] Leptospira IgG/IgM Rapid Test Test, Cassette Format (Whole Blood/Serum/Plasma) - 25 tests/Test
Leptospira IgG/IgM Rapid Test Test, Cassette Format (Whole Blood/Serum/Plasma) - 25 tests/Test
413.00 € 413.0 EUR
[0109-IGLLSER50ML] Innovative Grade US Origin Llama Serum 50ml
Innovative Grade US Origin Llama Serum 50ml
520.00 € 520.0 EUR
[0109-IIGGDS100ML] Immunoglobulin G (IgG) Depleted Human Serum 100ml
Immunoglobulin G (IgG) Depleted Human Serum 100ml
843.00 € 843.0 EUR
[0239-34042-500] IgG/IgM/IgA Depleted Human Serum Pooled Heat-Inactivated - 500 mL
IgG/IgM/IgA Depleted Human Serum Pooled Heat-Inactivated - 500 mL
17,275.00 € 17275.0 EUR
[0239-34042-5] IgG/IgM/IgA Depleted Human Serum Pooled Heat-Inactivated - 5 mL
IgG/IgM/IgA Depleted Human Serum Pooled Heat-Inactivated - 5 mL
569.00 € 569.0 EUR
[0239-34042-2] IgG/IgM/IgA Depleted Human Serum Pooled Heat-Inactivated - 2 mL
IgG/IgM/IgA Depleted Human Serum Pooled Heat-Inactivated - 2 mL
468.00 € 468.0 EUR
[0239-34042-10] IgG/IgM/IgA Depleted Human Serum Pooled Heat-Inactivated - 10 mL
IgG/IgM/IgA Depleted Human Serum Pooled Heat-Inactivated - 10 mL
738.00 € 738.0 EUR
[0239- 34041-100] IgG/IgM/IgA Depleted Human Complement Pooled Serum, 100 ml
IgG/IgM/IgA Depleted Human Complement Pooled Serum, 100 ml
6,520.00 € 6520.0 EUR
[0239-34041-2] IgG/IgM/IgA Depleted Human Complement Pooled Serum 2ml
IgG/IgM/IgA Depleted Human Complement Pooled Serum 2ml
572.00 € 572.0 EUR
[0239-34041-10] IgG/IgM/IgA Depleted Human Complement Pooled Serum - 10 mL
IgG/IgM/IgA Depleted Human Complement Pooled Serum - 10 mL
940.00 € 940.0 EUR
[0239-34041-1] IgG/IgM/IgA Depleted Human Complement Pooled Serum - 1 ml
IgG/IgM/IgA Depleted Human Complement Pooled Serum - 1 ml
536.00 € 536.0 EUR
[0239-34010-100] IgG/IgM Depleted Human Complement Pooled Serum, 100 ml
IgG/IgM Depleted Human Complement Pooled Serum, 100 ml
5,350.00 € 5350.0 EUR
[0881-11.PPA.K.3/2] INgezim PPA Compac (Blocking ELISA for the detection of specific antibodies to ASFV in porcine serum samples) - 2x 96 wells plates
INgezim PPA Compac (Blocking ELISA for the detection of specific antibodies to ASFV in porcine serum samples) - 2x 96 wells plates
672.00 € 672.0 EUR
[0863-HCS-F] Hybridoma Supplement, Serum-free, 50 ml
Hybridoma Supplement, Serum-free, 50 ml
183.00 € 183.0 EUR
[0239-34007-2] Human Serum Type AB Sterile Off-Clot (single donor) - 100 mL
Human Serum Type AB Sterile Off-Clot (single donor) - 100 mL
1,435.00 € 1435.0 EUR
[0239-34005-1] Human Serum Type AB Sterile Male Plasma Derived 100ml
Human Serum Type AB Sterile Male Plasma Derived 100ml
516.00 € 516.0 EUR
[0240-34005] Human Serum Type AB Sterile Male Plasma Derived - 100 mL
Human Serum Type AB Sterile Male Plasma Derived - 100 mL
618.00 € 618.0 EUR
[0239-34006-1] Human Serum Type AB Sterile Male Off-Clot Pooled - 5 ml
Human Serum Type AB Sterile Male Off-Clot Pooled - 5 ml
439.00 € 439.0 EUR
[0239-34006-2] Human Serum Type AB Sterile Male Off-Clot Pooled - 100 mL
Human Serum Type AB Sterile Male Off-Clot Pooled - 100 mL
730.00 € 730.0 EUR
  • 3
  • 4
  • 5
  • 6
  • 7

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)